Addressing Specific Hunger Patterns If a patient experiences intense head hunger or cravings that the GLP-1 is not fully suppressing, the stimulant effect of phentermine might be used to target those specific neurological triggers
But for individuals who have plateaued on semaglutide or who want the most aggressive pharmacological approach to weight loss, tirzepatide offers a meaningful step up in efficacy
Drug interactions are another critical consideration
When tirzepatide binds to GLP-1 and GIP receptors, it sends coordinated signals that can reduce appetite, slow gastric emptying and improve insulin responseworking together to enhance overall metabolic outcomes
You might even cut back on caffeine
Now a growing number of researchers, payers, and providers are exploring deliberate deprescription, which aims to taper some patients off their medication after they have taken it for a certain amount of time or lost a certain amount of weight